Die Datenschutz Einstellungen Ihres Browsers führen dazu, dass diese Seite nicht richtig funktioniert. Bitte öffnen Sie die Seite in einem neuen Tab. Alternativ können Sie Cross-Sitetracking in Ihrem Browser erlauben.
In neuem Tab öffnen

Join AiCuris


AiCuris - founded in 2006 - is a specialist for infectious diseases. Its focus comprises discovery, research and development of novel antiviral and antibacterial agents in the indications Human Cytomegalovirus, Herpes simplex, Hepatitis B, and (multi)resistant bacterial infections treated in the hospital. With its highly innovative Pipeline, AiCuris addresses specialist markets and severe, potentially life-threatening infections with high medical need. A major step for the company was the marketing authorization for Prevymis™ (Letermovir) in the US and Europe.

You can find an image film about AiCuris here.


Suchen Einfache Suche